|
| | 09900SB2403sam001 | - 2 - | LRB099 18409 MJP 45732 a |
|
|
| 1 | | (210 ILCS 85/6.23a new) |
| 2 | | Sec. 6.23a. Sepsis screening protocols. |
| 3 | | (a) Each hospital shall adopt, implement, and periodically |
| 4 | | update evidence-based protocols for the early recognition and |
| 5 | | treatment of patients with sepsis, severe sepsis, or septic |
| 6 | | shock (sepsis protocols) that are based on generally accepted |
| 7 | | standards of care. Sepsis protocols must include components |
| 8 | | specific to the identification, care, and treatment of adults |
| 9 | | and of children, and must clearly identify where and when |
| 10 | | components will differ for adults and for children seeking |
| 11 | | treatment in the emergency department or as an inpatient. These |
| 12 | | protocols must also include the following components: |
| 13 | | (1) a process for the screening and early recognition |
| 14 | | of patients with sepsis, severe sepsis, or septic shock; |
| 15 | | (2) a process to identify and document individuals |
| 16 | | appropriate for treatment through sepsis protocols, |
| 17 | | including explicit criteria defining those patients who |
| 18 | | should be excluded from the protocols, such as patients |
| 19 | | with certain clinical conditions or who have elected |
| 20 | | palliative care; |
| 21 | | (3) guidelines for hemodynamic support with explicit |
| 22 | | physiologic and treatment goals, methodology for invasive |
| 23 | | or non-invasive hemodynamic monitoring, and timeframe |
| 24 | | goals; |
| 25 | | (4) for infants and children, guidelines for fluid |
| 26 | | resuscitation consistent with current, evidence-based |
|
| | 09900SB2403sam001 | - 3 - | LRB099 18409 MJP 45732 a |
|
|
| 1 | | guidelines for severe sepsis and septic shock with defined |
| 2 | | therapeutic goals for children; |
| 3 | | (5) identification of the infectious source and |
| 4 | | delivery of early broad spectrum antibiotics with timely |
| 5 | | re-evaluation to adjust to narrow spectrum antibiotics |
| 6 | | targeted to identified infectious sources; and |
| 7 | | (6) criteria for use, based on accepted evidence of |
| 8 | | vasoactive agents. |
| 9 | | (b) Each hospital shall ensure that professional staff with |
| 10 | | direct patient care responsibilities and, as appropriate, |
| 11 | | staff with indirect patient care responsibilities, including, |
| 12 | | but not limited to, laboratory and pharmacy staff, are |
| 13 | | periodically trained to implement the sepsis protocols |
| 14 | | required under subsection (a). The hospital shall ensure |
| 15 | | updated training of staff if the hospital initiates substantive |
| 16 | | changes to the sepsis protocols. |
| 17 | | (c) Each hospital shall be responsible for the collection |
| 18 | | and utilization of quality measures related to the recognition |
| 19 | | and treatment of severe sepsis for purposes of internal quality |
| 20 | | improvement. |
| 21 | | (d) The evidence-based protocols adopted under this |
| 22 | | Section shall be provided to the Department upon the |
| 23 | | Department's request. |
| 24 | | (e) Hospitals submitting sepsis data as required by the |
| 25 | | Center for Medicare and Medicaid Services Hospital Inpatient |
| 26 | | Quality Reporting program as of fiscal year 2016 are presumed |
|
| | 09900SB2403sam001 | - 4 - | LRB099 18409 MJP 45732 a |
|
|
| 1 | | to meet the sepsis protocol requirements outlined in this |
| 2 | | Section. |
| 3 | | (f) Subject to appropriation, the Department shall: |
| 4 | | (1) recommend evidence-based sepsis definitions and |
| 5 | | metrics that incorporate evidence-based findings, |
| 6 | | including appropriate antibiotic stewardship, and that |
| 7 | | align with the National Quality Forum, the Centers for |
| 8 | | Medicare and Medicaid Services, the Agency for Healthcare |
| 9 | | Research and Quality, and The Joint Commission; |
| 10 | | (2) establish and use a methodology for collecting, |
| 11 | | analyzing, and disclosing the information collected under |
| 12 | | this Section, including collection methods, formatting, |
| 13 | | and methods and means for aggregate data release and |
| 14 | | dissemination; |
| 15 | | (3) complete a digest of efforts and recommendations no |
| 16 | | later than 12 months after the effective date of this |
| 17 | | amendatory Act of the 99th General Assembly; the digest may |
| 18 | | include Illinois-specific data, trends, conditions, or |
| 19 | | other clinical factors; a summary shall be provided to the |
| 20 | | Governor and General Assembly and shall be publicly |
| 21 | | available on the Department's website; and |
| 22 | | (4) consult and seek input and feedback prior to the |
| 23 | | proposal, publication, or issuance of any guidance, |
| 24 | | methodologies, metrics, rulemaking, or any other |
| 25 | | information authorized under this Section from statewide |
| 26 | | organizations representing hospitals, physicians, advanced |
|
| | 09900SB2403sam001 | - 5 - | LRB099 18409 MJP 45732 a |
|
|
| 1 | | practice nurses, pharmacists, and long-term care |
| 2 | | facilities. Public and private hospitals, epidemiologists, |
| 3 | | infection prevention professionals, health care |
| 4 | | informatics and health care data professionals, and |
| 5 | | academic researchers may be consulted. |
| 6 | | If the Department receives an appropriation and carries out |
| 7 | | the requirements of paragraphs (1), (2), (3), and (4), then the |
| 8 | | Department may adopt rules concerning the collection of data |
| 9 | | from hospitals regarding sepsis and requiring that each |
| 10 | | hospital shall be responsible for reporting to the Department. |
| 11 | | Any publicly released hospital-specific information under |
| 12 | | this Section is subject to data provisions specified in Section |
| 13 | | 25 of the Hospital Report Card Act.
|
| 14 | | Section 99. Effective date. This Act takes effect upon |
| 15 | | becoming law.".
|